A detailed history of Rtw Investments, LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 350,000 shares of RGNX stock, worth $3.76 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
350,000
Holding current value
$3.76 Million
% of portfolio
0.12%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$12.17 - $24.61 $4.26 Million - $8.61 Million
350,000 New
350,000 $7.37 Million
Q3 2021

Nov 15, 2021

BUY
$29.09 - $45.68 $2.55 Million - $4 Million
87,623 Added 4.98%
1,845,366 $77.4 Million
Q2 2021

Aug 13, 2021

BUY
$32.46 - $40.48 $43.5 Million - $54.3 Million
1,341,166 Added 321.95%
1,757,743 $68.3 Million
Q1 2021

May 14, 2021

BUY
$33.61 - $49.95 $4.51 Million - $6.71 Million
134,317 Added 47.59%
416,577 $14.2 Million
Q4 2020

Feb 16, 2021

SELL
$26.52 - $49.35 $959,334 - $1.79 Million
-36,174 Reduced 11.36%
282,260 $12.8 Million
Q3 2020

Nov 16, 2020

BUY
$27.01 - $40.26 $64,986 - $96,865
2,406 Added 0.76%
318,434 $8.76 Million
Q2 2020

Aug 14, 2020

BUY
$27.75 - $43.44 $67,210 - $105,211
2,422 Added 0.77%
316,028 $11.6 Million
Q1 2020

May 15, 2020

BUY
$21.5 - $54.2 $171,892 - $433,329
7,995 Added 2.62%
313,606 $10.2 Million
Q4 2019

Feb 14, 2020

BUY
$34.54 - $44.87 $498,861 - $648,057
14,443 Added 4.96%
305,611 $12.5 Million
Q3 2019

Nov 14, 2019

SELL
$31.84 - $50.88 $2.45 Million - $3.91 Million
-76,872 Reduced 20.89%
291,168 $10.4 Million
Q2 2019

Aug 14, 2019

SELL
$42.0 - $59.29 $3.49 Million - $4.93 Million
-83,142 Reduced 18.43%
368,040 $18.9 Million
Q1 2019

May 15, 2019

SELL
$40.82 - $62.45 $24.5 Million - $37.4 Million
-599,063 Reduced 57.04%
451,182 $25.9 Million
Q4 2018

Feb 14, 2019

SELL
$39.11 - $75.15 $16 Million - $30.7 Million
-408,883 Reduced 28.02%
1,050,245 $44.1 Million
Q3 2018

Nov 14, 2018

SELL
$65.0 - $82.15 $40.3 Million - $51 Million
-620,427 Reduced 29.83%
1,459,128 $110 Million
Q2 2018

Aug 14, 2018

BUY
$27.2 - $74.35 $5.49 Million - $15 Million
201,788 Added 10.75%
2,079,555 $149 Million
Q1 2018

May 14, 2018

BUY
$24.05 - $37.5 $7.61 Million - $11.9 Million
316,557 Added 20.28%
1,877,767 $56.1 Million
Q4 2017

Feb 14, 2018

BUY
$26.0 - $34.6 $577,330 - $768,293
22,205 Added 1.44%
1,561,210 $51.9 Million
Q3 2017

Nov 14, 2017

BUY
$18.0 - $32.95 $27.7 Million - $50.7 Million
1,539,005
1,539,005 $50.7 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $465M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.